Film production

Thinking about buying stock in Annovis Bio, Meten Edtechx Education, Onconova Therapeutics, General Electric, or AMC Entertainment?

Retrieved on: 
Friday, May 21, 2021
Communication design, Design, Film production, Multimedia, Human activities, Articles

b"InvestorsObserver's PriceWatch Alerts are based on our proprietary scoring methodology.

Key Points: 
  • b"InvestorsObserver's PriceWatch Alerts are based on our proprietary scoring methodology.
  • Each stock is evaluated based on short-term technical, long-term technical and fundamental factors.
  • Each of those scores is then combined into an overall score that determines a stock's overall suitability for investment.\nView original content to download multimedia: http://www.prnewswire.com/news-releases/thinking-about-buying-stock-in-a...\n"

2020 ACM A.M.Turing Award Winner, Alfred Aho to be featured in Collective[i] Forecast speaker series

Retrieved on: 
Thursday, May 20, 2021
Software, Operating systems, Design, Computing, Communication design, Film production, Multimedia, Twitter, Computational thinking, Aho

From the cars we drive to the cell phones we use, the technology that we rely on couldn't exist without the computer software that powers it.

Key Points: 
  • From the cars we drive to the cell phones we use, the technology that we rely on couldn't exist without the computer software that powers it.
  • This software, although taken for granted by many, drives not only the present world we live in, but also lays the foundation for future innovation.\nCollective[i] Forecast featuring Professor Aho will take place today, Thursday, May 20, 2021 at 4:00 P.M. EST.
  • During this interactive discussion, Professor Aho will present his perspective on computational thinking and compiler design.
  • Follow us on LinkedIn or Twitter .\nView original content to download multimedia: http://www.prnewswire.com/news-releases/2020-acm-amturing-award-winner-a...\n"

From Takeoff To Touchdown, Personal Health Tops Typical Travel Considerations As Consumers Return To The Road

Retrieved on: 
Thursday, May 20, 2021
Communication design, Design, Film production, Multimedia, Human activities

"Health is no longer an afterthought, but has moved to the front seat of the planning process, perhaps for good.

Key Points: 
  • "Health is no longer an afterthought, but has moved to the front seat of the planning process, perhaps for good.
  • "\nAfter more than a year of uncertainty, the priority of personal/family health while traveling is changing how travelers plan and what they research.
  • said Dr. Zelis.
  • To learn more about MDLIVE, visit www.MDLIVE.com , download our app, or text "Sophie" to MDLIVE (635483) to register.\nView original content to download multimedia: http://www.prnewswire.com/news-releases/from-takeoff-to-touchdown-person...\n'

TechTalk Summits Returns To Live In-person Events Starting June 3

Retrieved on: 
Wednesday, May 19, 2021
Communication design, Design, Film production, Multimedia

TechTalk\'s sponsor base and audience of enterprise tech professionals are anxious for the higher level of interaction and engagement, which is the signature of these live events.

Key Points: 
  • TechTalk\'s sponsor base and audience of enterprise tech professionals are anxious for the higher level of interaction and engagement, which is the signature of these live events.
  • TechTalk\'s full calendar of live events will ramp up towards the end of July 2021.\n"We\'re excited to get back on the road and do what we do best," said Mike Healy, TechTalk Summits Founder and Managing Partner.
  • Our upscale events have the capabilities to reach professional audiences across the country who are looking for answers to their tech complexities.
  • To learn more about TechTalk Summits visit us at www.techtalksummits.com .\nView original content to download multimedia: http://www.prnewswire.com/news-releases/techtalk-summits-returns-to-live...\n'

Coeptis Pharmaceuticals Enters into Exclusive Option Agreements with VyGen-Bio to Co-develop Technologies Designed to Improve the Treatment of CD38-Related Cancers

Retrieved on: 
Tuesday, May 18, 2021
Contract law, Film production, Option, Fee, Multiple myeloma, Market economics), Economy, Articles

The first indication is expected to be multiple myeloma, an incurable cancer of plasma cells.

Key Points: 
  • The first indication is expected to be multiple myeloma, an incurable cancer of plasma cells.
  • Per the option agreement, Coeptis has paid VyGen-Bio a non-refundable fee for the exclusive option to purchase the co-development rights to the technology.
  • Per the option agreement, Coeptis has paid VyGen-Bio a non-refundable fee for the exclusive option to purchase the co-development rights to the technology.
  • Additional factors are discussed in the Company\'s filings with the U.S. Securities and Exchange Commission, which are available for review at www.sec.gov .

Newsela Launches "Learning Found" Campaign

Retrieved on: 
Monday, May 10, 2021
Articles, Education, Human activities, Communication design, Design, Film production, Multimedia, Educational psychology, Educational technology

There is real danger in education leaders over-rotating on the need for self-paced remediation and repetitive skills practice in response to the current crisis.

Key Points: 
  • There is real danger in education leaders over-rotating on the need for self-paced remediation and repetitive skills practice in response to the current crisis.
  • Massive decline in student engagement is a result of too many impediments standing in the way of a student\'s desire to engage in classroom learning.
  • To learn more about the "Learning Found" campaign, visit the microsite at LearningFound.com .\nNewsela takes authentic, real world content from trusted sources and makes it instruction ready for K-12 classrooms.
  • With over 14,000 texts in our platform and 10 new texts published every day across 20+ genres, Newsela enables educators to go deep on any subject they choose.\nView original content to download multimedia: http://www.prnewswire.com/news-releases/newsela-launches-learning-found-...\n'

YASC Global Gives Yardi Software Users an Inside Look at Innovation

Retrieved on: 
Wednesday, April 28, 2021
Communication design, Design, Film production, Multimedia, Human activities

Using the Yardi Aspire learning platform, attendees from commercial, residential, PHA, senior living and other real estate markets create customized curricula from more than 280 classes.

Key Points: 
  • Using the Yardi Aspire learning platform, attendees from commercial, residential, PHA, senior living and other real estate markets create customized curricula from more than 280 classes.
  • All Yardi clients are automatically enrolled in the conference.\nAlong with education, social elements have always been central to the YASC experience, which dates to 1999.
  • "\nSee how YASC Global can help Yardi clients run their organizations more efficiently.\nYardi develops and supports industry-leading investment and property management software for all types and sizes of real estate companies.
  • For more information on how Yardi is Energized for Tomorrow, visit yardi.com .\nView original content to download multimedia: http://www.prnewswire.com/news-releases/yasc-global-gives-yardi-software...\n'

Health iQ Launches an Innovative New Storytelling Module to Its Real-World Data Platform

Retrieved on: 
Tuesday, April 20, 2021
Film, Visual arts, Film production, Filmmaking, Infographics, Storyboard

and LONDON, April 20, 2021 /PRNewswire/ -- Real-world evidence provider Health iQ has launched a new module to add to its collection of cutting-edge healthcare analytics solutions.\nPowered by Vantage, the Storyboard module combines the most complete disease, treatment and procedure level data available to present a multi-dimensional view of the healthcare landscape.

Key Points: 
  • and LONDON, April 20, 2021 /PRNewswire/ -- Real-world evidence provider Health iQ has launched a new module to add to its collection of cutting-edge healthcare analytics solutions.\nPowered by Vantage, the Storyboard module combines the most complete disease, treatment and procedure level data available to present a multi-dimensional view of the healthcare landscape.
  • Storyboard allows us to use RWE to tell that story in a new and unique way.
  • "\n"Our new Storyboard module cuts through the data to present ideas in a highly visual, digestible and memorable way.
  • This enables organisations to present a robust, reliable and relatable story that engages stakeholders and supports the case for change," noted Jilani Gulam, CEO of Health iQ.\nFor more information on Storyboard, visit https://landing.healthiq.co.uk/storyboard\n'

Global Option and Evaluation Partnership Terms and Agreements in Pharma, Biotech and Diagnostics Report 2021 - ResearchAndMarkets.com

Retrieved on: 
Tuesday, April 13, 2021
Biotechnology, Pharmaceutical, Health, Film production, Option, Patent law

b'The "Global Option and Evaluation Partnership Terms and Agreements in Pharma, Biotech and Diagnostics 2014-2021" report has been added to ResearchAndMarkets.com\'s offering.\nThe Global Option and Evaluation Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2014-2021 report provides comprehensive access to available records for over 1,000 option and evaluation deals, including contract documents where available.\nThis report provides details of the latest option and evaluation agreements announced in the pharmaceutical, biotechnology and diagnostic sectors.

Key Points: 
  • b'The "Global Option and Evaluation Partnership Terms and Agreements in Pharma, Biotech and Diagnostics 2014-2021" report has been added to ResearchAndMarkets.com\'s offering.\nThe Global Option and Evaluation Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2014-2021 report provides comprehensive access to available records for over 1,000 option and evaluation deals, including contract documents where available.\nThis report provides details of the latest option and evaluation agreements announced in the pharmaceutical, biotechnology and diagnostic sectors.
  • Fully revised and updated, the report provides details of option and evaluation agreements from 2014 to 2021.\nThere are two major forms of deal term that allow a party to a deal to secure rights to an asset subject to a future event namely, option and evaluation.\nEvaluation agreements allow a party to the deal to obtain rights to a technology or compound, subject to a period of time to evaluate the quality, scope and applicability of the technology to its intended endpoint.
  • Normally the technology is at an early stage and/or unproven and the partnering company wishes to assess the technology as part of the due diligence process in advance of signing a long term licensing agreement.\nEvaluation agreements have been a mainstay of technology licensing from the earliest days.\nAn option agreement differs in that the option is often an integral part of an agreement already entered by the parties, providing the party with the option right to retain or extend certain rights to the technology already partnered.\nOption agreements are becoming increasingly popular as they create additional flexibility within a deal for additional rights that the parties do not wish to commit at the outset of the agreement.\nThis report focuses on option and evaluation agreements and clauses within broader agreements between big pharma-big pharma, big pharma - smaller company, and smaller company-smaller company, providing a detailed insight into all such deals.\nGlobal Option and Evaluation Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2014-2021 provides the reader with the following key benefits:\nInsight into the terms included in a option and evaluation agreement, together with real world clause examples\nAvailable deals are listed by:\n'

Thinking about buying stock in Palantir Technologies, Super League Gaming, Phunware, Humanigen, or BioXcel Therapeutics?

Retrieved on: 
Friday, March 12, 2021
Communication design, Design, Film production, Multimedia, Stock market, Articles, Human activities

InvestorsObserver's PriceWatch Alerts are based on our proprietary scoring methodology.

Key Points: 
  • InvestorsObserver's PriceWatch Alerts are based on our proprietary scoring methodology.
  • Each stock is evaluated based on short-term technical, long-term technical and fundamental factors.
  • Each of those scores is then combined into an overall score that determines a stock's overall suitability for investment.
  • View original content to download multimedia: http://www.prnewswire.com/news-releases/thinking-about-buying-stock-in-p...